Iovance Biotherapeutics broke out to fresh 52-week highs and has held above the breakout zone, with volume running more than double the recent average on the move. Trend strength is elevated and buyers have been firmly in control, though the stock is pushing into extended territory after such a sharp advance, so some near-term cooling or chop wouldn't be surprising even within an intact uptrend. The stop reference sits just below the area that supported the breakout, keeping the invalidation point relatively tight, while both targets are set using that same distance projected higher.

Educational content only, not personalized investment advice, and not a recommendation to buy or sell any security. Swing trading carries substantial risk of loss, including the potential loss of principal — use your own risk management (position sizing, stop-loss levels) and do your own research before acting. Past signals do not guarantee future performance.